Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond R Mattingly

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Cancers|January 11, 2024
Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 DendrimersJohn J Reiners, Patricia A Mathieu, Mary Gargano, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 28, 2008
Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatinJonathan W Wojtkowiak, Farid Fouad, Daniel T LaLonde, et al.
Journal of Medicinal Chemistry|June 9, 2007
Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitorsMichelle K Clark, Sarah A Scott, Jonathan Wojtkowiak, et al.
Biochemical Pharmacology|June 27, 2006
Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1Joshua T Dilworth, Janice M Kraniak, Jonathan W Wojtkowiak, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2005
The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell linesRaymond R Mattingly, Janice M Kraniak, Joshua T Dilworth, et al.
Breast Cancer Research : BCR|May 17, 2017
Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situMansoureh Sameni, Dora Cavallo-Medved, Omar E Franco, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 21, 2010
A novel geranylgeranyl transferase inhibitor in combination with lovastatin inhibits proliferation and induces autophagy in STS-26T MPNST cellsKomal M Sane, Michelle Mynderse, Daniel T Lalonde, et al.
BMC Cancer|August 14, 2015
Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migrationKingsley O Osuala, Mansoureh Sameni, Seema Shah, et al.
Neoplasia (New York, N.Y.)|November 9, 2013
Acid-mediated tumor proteolysis: contribution of cysteine cathepsinsJennifer M Rothberg, Kate M Bailey, Jonathan W Wojtkowiak, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cancers|January 11, 2024
Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 DendrimersJohn J Reiners, Patricia A Mathieu, Mary Gargano, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 28, 2008
Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatinJonathan W Wojtkowiak, Farid Fouad, Daniel T LaLonde, et al.
Journal of Medicinal Chemistry|June 9, 2007
Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitorsMichelle K Clark, Sarah A Scott, Jonathan Wojtkowiak, et al.
Biochemical Pharmacology|June 27, 2006
Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1Joshua T Dilworth, Janice M Kraniak, Jonathan W Wojtkowiak, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2005
The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell linesRaymond R Mattingly, Janice M Kraniak, Joshua T Dilworth, et al.
Breast Cancer Research : BCR|May 17, 2017
Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situMansoureh Sameni, Dora Cavallo-Medved, Omar E Franco, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 21, 2010
A novel geranylgeranyl transferase inhibitor in combination with lovastatin inhibits proliferation and induces autophagy in STS-26T MPNST cellsKomal M Sane, Michelle Mynderse, Daniel T Lalonde, et al.
BMC Cancer|August 14, 2015
Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migrationKingsley O Osuala, Mansoureh Sameni, Seema Shah, et al.
Neoplasia (New York, N.Y.)|November 9, 2013
Acid-mediated tumor proteolysis: contribution of cysteine cathepsinsJennifer M Rothberg, Kate M Bailey, Jonathan W Wojtkowiak, et al.
Pageof 6